Ethnic differences in methacholine responsiveness and word descriptors in African Americans, Hispanic-Mexican Americans, Asian-Pacific Islanders, and Whites with mild asthma

Journal of Asthma

Volumn 47, Issue 4, 2010, Pages 388-396

  Hardie, Grace ^a   Liu, Rebecca ^a   Darden, Jennifer ^a   Gold, Warren M ^b  

^a SAN FRANCISCO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asthma; Bronchoconstriction; Ethnicity; Word descriptors

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; METHACHOLINE;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN AMERICAN; ASTHMA; BORG SCALE; BRONCHUS HYPERREACTIVITY; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; COUGHING; CULTURAL ANTHROPOLOGY; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DYSPNEA; ETHNIC DIFFERENCE; ETHNIC WORD DESCRIPTORS; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH EDUCATION; HEALTH PRACTITIONER; HISPANIC; HUMAN; LANGUAGE; LOWER RESPIRATORY TRACT; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PREDICTION; PROVOCATION TEST; RATING SCALE; SELF REPORT; SYMPTOM; THROAT TIGHTNESS; UPPER RESPIRATORY TRACT OBSTRUCTION; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; ASTHMA; BRONCHIAL PROVOCATION TESTS; CONTINENTAL POPULATION GROUPS; CROSS-CULTURAL COMPARISON; FEMALE; HUMANS; LANGUAGE; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; YOUNG ADULT;

EID: 77953336234     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2010.481341     Document Type: Article

References (46)

1. Hardie GE, Janson S, Gold WM, Carrieri-Kohlman V, Boushey HA. Ethnic differences: word descriptors used by African American and Caucasian asthma patients during induced bronchoconstriction. Chest 2000; 117:935-943.
2. Hardie GE, Brown J, Gold WM. Adrenergic responsiveness: FEV1 and symptom differences in Whites and African Americans with mild asthma. J Asthma 2007; 44:621-628.
3. Diette GB, Rand C. The contributing role of health-care communication to health disparities for minority patients with asthma. Chest 2007; 132:802s-809s.
4. Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K, et al. Can asthma be improved by understanding the patient's perspective? BMC Pulm Med 2007; 7:8, 1-11.
5. Burdon J, Juniper W, Killian K, et al. The perception of breathlessness in asthma. Am Rev Resp Dis 1982; 117:71-75.
6. Wilson R, Jones P. A comparison of the visual analogue scale and the modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci 1989; 76:277-282.
7. Adams L, Chronos N, Guz A. The measurement of breathlessness induced in normal subjects: validity of two scaling devices. Clin Sci 1985; 69:7-16
8. American Thoracic Society and European Society Task Force: Standardization of lung function testing. General considerations for lung function testing. Edited by Bursasco V, Crapo R,Viegi G. Eur Resp J 2005; 26:153-161.
9. Hankinson JL, Odencrantz JR, Feden KB. Spirometric reference values form a sample of the general US population. Am J Resp Crit Care Med 1999; 126:825-828.
10. American Thoracic Society. Standards of spirometry. 1994 update. Am J Respir Care Med 1995; 152:1107-1136
11. American Thoracic Society. Guidelines formethacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000; 161:309-329.
12. Gold WM. Pulmonary function testing. In: Murray J, Nadel J, Mason R, Boushey HA, eds. Textbook of Respiratory Medicine. 3rd ed. Philadelphia, PA, 2000:781-881.
13. Mahler D, Harver A, Lentine T, Scott JA, Beck K, Schwartzstein RM. Descriptors of breathlessness in cardiorespiratory diseases. Am J Crit Care Med 1996; 154:1537-11363
14. El-Eklaby A, Brianas L, Skowronski ME, Coreno AJ, et al. Impact of race on the severity of acute episodes of asthma and adrenergic responsiveness. Am J Crit Care Med 2006; 174:508-513.
15. Elliott M, Adams L, Cockcroft A, MacRae KD, Murphy K, Guz A. The language of breathlessness: use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis 1991; 144:826-832.
16. Simon P, Schwartzstein R, Weiss J, Fencl V, Teghtsoonian M, Weinberger SE. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990; 1009-1014.
17. Coli C, Picariello M, Stendardi L, Grazzinei M, Birazzi B, Duranti R, et al. Is there a link between qualitative descriptors and the quantitative perception of dyspnea in asthma? Chest 2006; 130:436-441.
18. Chetta A, Castagnaro A, Foresi A, Del Donno M, Pisi G, Malorgio R, et al. Assessment of breathlessness perception by Borg scale in asthmatics patients: reproducibility and applicability to different stimuli. J Asthma 2003; 40:323-329.
19. Ottanelli R, Rosi E, Romaqnoli I, Ronchi MC, Lanni B, Grazzini M, et al. Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma. Clin Sci 2000; 98:681-687.
20. OBryne PM, Pedersen S, Lamm Cj, TanWC, Busse WW. Severe exacerbations and decline in lung function in asthma.AmJ Crit CareMed 2009; 179: 19-24.
21. Hankinson JL, Kawut SM, Shabar E, Smith LJ, et al. Performance of ATS-recommended spirometry reference values in a multiethnic sample of adults: the MESA lung study. Chest 2010; Jan: 137(1): 138-145, Epub 2009 Sep 9.
22. Trochtenberg D, BeLue R, Piphus S, Washington N. Differing reports of asthma symptoms in African Americans and Caucasians. J Asthma 2008; 45:165-170.
23. Weiner P, Beckerman M, Berar-Yanay N, Magadle R. The perception of dyspnea after bronchoconstriction and bronchodilation in patients with asthma. Respir Med 2003; 97:1120-1125.
24. Pleis JR, Barnes PM. A comparison of respiratory conditions between multiple race adults and their single race counterparts: an analysis of based on American Indian/Alaska Native and white adults. Ethn Health 2008; 13:399-415.
25. Mancuso CA, Rincon, M. Asthma patients' assessment of health care and medical decision making: the role of health literacy. J Asthma 2006; 43:41-44.
26. Hunninghake GM, Weiss ST, Celedon JC. Asthma in Hispanics. Am J Respir Crit Care Med 2006; 173:143-163.
27. Cuttitta, G, Cibella F, Bellia V, Grassi V, Cossi S, Buccheri S, et al. Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma. Chest 2001; 119:1685-1690.
28. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE,Wenzel SF. Risk factors associated with persistent airflow limitation in severe or difficult-totreat asthma. Chest 2007; 132:1882-1889.
29. Currie GP, Jackson CM, Lee DK, Lipworth BJ. Determinants of airway hyperresponsiveness in mild asthma. Ann Allergy Asthma Immunol 2003; 90:560-563.
30. Choudry S, Burchard EG, Borrell, LN, Tang H, Gomez I, Naqvi M, et al. Ancestry-Environment interactions and asthma risk among Puerto Ricans. Am J Respir Crit Care Med 2006; 174:1088-1093.
31. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100:3184-3188.
32. Burchard EG, Avila PC, Nazario S, Casal J, Torres A, Rodriquez-Santana JR, et al. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med 2004; 169:386-392.
33. Jang AS, Choi IS. Increased perception of dyspnea by inhalation of short acting beta2 agonist in patients with asthma of varying severity.Ann Allergy Asthma Immunol 2000; 84:79-83.
34. Parker AL. Airway reactivity is a determinant of bronchodilator responsiveness after methacholine-induced bronchoconstriction. J Asthma 2004; 41:671-677.
35. Barley EA, Jones PW. Adapting to asthma: are some asthma effects acceptable? J Asthma 2006; 43:433-438.
36. Klatsky AL, Tekawa I. Health problems and hospitalizations among Asian- American ethnic groups. Ethn Dis 2005; 15:753-760.
37. Holquin F, Mannino DM, Anto, J, Mott J. Country of birth as a risk factor for asthma among Mexican Americans. Am J Resp Crit Care Med 2005; 171:102-108.
38. Wraight JM, Hancox RJ, Herbison GP, Cowan JO, Flannery EM, Taylor DR. Bronchodilator tolerance: the impact of increasing bronchoconstriction. Eur Resp J 2003; 21:810-815.
39. Davis AM, Kreutzer R, Lipsett M, King G, Shaikh N. Asthma prevalence in Hispanic and Asian American ethnic subgroups: results from the California Healthy Kids Survey. Pediatrics 2006; 118:e363-e369.
40. Tcheurekdjian H, Thyne SM,Williams LK, Via, M, Rodriquez-Clintron W, Avila, PC, Burchard, EG. Augmentation of bronchodilator responsiveness by leukotrienemodifiers in Puerto Rican andMexican children. AnnAllergy Asthma Immunol 2009; 102:510-517.
41. Hancock DB, Romieu I, Shi M, Sienna-Monge JJ, Wu H, et al. Genomewide association study implicates chromosome 9q21.31as a susceptibility locus for asthma in Mexican children. PloS Genet 2009; (8):e1000623.
42. Kramer H, Han C, Post W, Goff D, Diez-Roux A, Jinagouda S, Shea S. Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of artherosclerosis (MESA). Am J Hypertens 2004; 17:963-970.
43. Sugikawa T, Garcia CA,Martinez E,Vianna EO.Cough and dyspnea during bronchoconstriction: comparison of different stimuli. Open Access 2009; Jun: 1-7.
44. Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, Jinagouda S, et al. Racial/ethnic differences in hypertension and hypertension treatment and control in the Multi-Ethnic Study of Artherosclerosis (MESA). Ann J Hypertens 2004; 17:963-970.
45. Han J, Zhu Y, Li S, Chen X, Put C, Van deWoestijne KP, et al. Respiratory complaints in Chinese; cultural and diagnostic specificities. Chest 2005; 127:1942-1951.
46. Ambrosino N, Serradori M. Determining the cause of dyspnoea: linguistic and biological descriptors. Chr Respir Dis 2006; 3:117-122.